fda announcement semaglutide 🚨 Ends Shortage The FDA has officially declared an end to the shortage of semaglutide, the active ingredient in the popular medications Ozempic and Wegovy. This signals a significant New project announcement: HHS‑OIG is

Oral tolerance

There are crackdown efforts: The US Food and Drug Administration says people should buy their drugs from licensed pharmacies, with valid prescriptions

Tirzepatide does reduce liver fat the SURMOUNT and SURPASS programs reported meaningful improvements but the magnitude appears to be less than what the glucagon-containing compounds achieve

Patients should avoid breastfeeding for at least 4 weeks after last use [21]

In clinical trials, patients achieved an average of 14.9% body weight loss

Over 710 days, you may notice that appetite returns, portion control becomes harder, and cravings intensify as drug levels drop below the effective threshold your body has adapted to during treatment